Publications by authors named "Irene Fuss"

Claim this Profile
P
Phase 1 trial of the novel bispecific molecule H22xKi-4 in patients with refractory Hodgkin lymphoma.
Peter Borchmann, Roland Schnell, Irene Fuss, Oliver Manzke, Thomas Davis

Bloodยท November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis